Study of 3 buprenorphine hemiadipate(10mg)/naloxone(10mg) treatments

• Research type

  Research Study

• Full title

  An Open-label, Randomised, Three-way, Cross-over Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Formulations of RBP-6300 10 mg in Healthy Volunteers Under a Naltrexone Block in the Presence and Absence of Food.

• IRAS ID

  138366

• Contact name

  Adrian Stewart

• Contact email

  adrian.stewart@celerion.com

• Sponsor organisation

  Reckitt Benckiser Pharmaceuticals Inc.

• Eudract number

  2012-002408-42

• ISRCTN Number

  To be registered

• REC name

  Wales REC 1

• REC reference

  13/WA/0257

• Date of REC Opinion

  13 Sep 2013

• REC opinion

  Further Information Favourable Opinion